BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/22/2017 1:25:16 PM | Browse: 1543 | Download: 2391
Publication Name World Journal of Transplantation
Manuscript ID 32642
Country United Kingdom
ISSN 2220-3230 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Minireviews
Article Title Polyoma virus nephropathy in kidney transplantation
Manuscript Source Invited Manuscript
All Author List Jacob RW Scadden, Adnan Sharif, Kassi Skordilis and Richard Borrows
Funding Agency and Grant Number
Corresponding Author Richard Borrows, Doctor, Doctor, Department of Kidney Transplantation, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2TH, United Kingdom. richard.borrows@uhb.nhs.uk
Key Words Polyoma; Kidney; Transplant; Infection; Virus
Core Tip Prior to its recognition as a separate entity, kidney transplant infection with the polyoma virus, BK virus (BKV), and the ensuing viral nephropathy (BKVN) portended a poor prognosis. But with the advent of heightened clinical suspicion and improved diagnostics the prognosis has improved considerably. Blood and urine polymerase chain reaction testing allows invasive investigation (i.e., transplant biopsy) to be selective and appropriate. Peripheral blood assays of anti-BKV cell mediated immunity offers potential for refining risk stratification. While conventional antiviral agents have failed to show utility to date, reduction of immunosuppression currently represents the most effective and proven treatment for BKVN.
Publish Date 2017-12-22 13:25
Citation Scadden JRW, Sharif A, Skordilis K, Borrows R. Polyoma virus nephropathy in kidney transplantation. World J Transplant 2017; 7(6): 329-338
URL http://www.wjgnet.com/2220-3230/full/v7/i6/329.htm
DOI http://dx.doi.org/10.5500/wjt.v7.i6.329
Full Article (PDF) WJT-7-329.pdf
Full Article (Word) WJT-7-329.doc